학술논문
PET With 11 C-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH -Mutant Lower-Grade Glioma.
Document Type
Article
Author
Source
Clinical Nuclear Medicine; Jul2022, Vol. 47 Issue 7, p569-574, 6p
Subject
Language
ISSN
03639762